There were no significant statistical differences in sex, blood pressure, hypertension, diabetes, dyslipidemia, coronary artery disease, stroke, and blood lipid levels in both FABP2 (Table 4) and FABP1 (Table 5) genotypes. This evidence concerns the gene FABP2 and metabolic syndrome.